| An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival LD Miller, J Smeds, J George, VB Vega, L Vergara, A Ploner, Y Pawitan, ... Proceedings of the National Academy of Sciences 102 (38), 13550-13555, 2005 | 1374 | 2005 |
| A global map of p53 transcription-factor binding sites in the human genome CL Wei, Q Wu, VB Vega, KP Chiu, P Ng, T Zhang, A Shahab, HC Yong, ... Cell 124 (1), 207-219, 2006 | 1311 | 2006 |
| High-fidelity mRNA amplification for gene profiling E Wang, LD Miller, GA Ohnmacht, ET Liu, FM Marincola Nature biotechnology 18 (4), 457-459, 2000 | 858 | 2000 |
| Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Y Pawitan, J Bjöhle, L Amler, AL Borg, S Egyhazi, P Hall, X Han, ... Breast cancer research 7 (6), 1-12, 2005 | 833 | 2005 |
| Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer AV Ivshina, J George, O Senko, B Mow, TC Putti, J Smeds, T Lindahl, ... Cancer research 66 (21), 10292-10301, 2006 | 746 | 2006 |
| Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-κB-responsive genes in cervical keratinocytes M Nees, JM Geoghegan, T Hyman, S Frank, L Miller, CD Woodworth Journal of virology 75 (9), 4283-4296, 2001 | 443 | 2001 |
| Ferroportin and iron regulation in breast cancer progression and prognosis ZK Pinnix, LD Miller, W Wang, R D’Agostino, T Kute, MC Willingham, ... Science translational medicine 2 (43), 43ra56-43ra56, 2010 | 375 | 2010 |
| Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer CN Landen, B Goodman, AA Katre, AD Steg, AM Nick, RL Stone, ... Molecular cancer therapeutics 9 (12), 3186-3199, 2010 | 366 | 2010 |
| Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients S Calza, P Hall, G Auer, J Bjöhle, S Klaar, U Kronenwett, ET Liu, L Miller, ... Breast Cancer Research 8 (4), 1-9, 2006 | 350 | 2006 |
| Transcriptome analysis of zebrafish embryogenesis using microarrays S Mathavan, SGP Lee, A Mak, LD Miller, KRK Murthy, KR Govindarajan, ... PLoS Genet 1 (2), e29, 2005 | 335 | 2005 |
| Discovery of estrogen receptor α target genes and response elements in breast tumor cells CY Lin, A Ström, VB Vega, SL Kong, AL Yeo, JS Thomsen, WC Chan, ... Genome biology 5 (9), 1-18, 2004 | 315 | 2004 |
| Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression SH Lam, YL Wu, VB Vega, LD Miller, J Spitsbergen, Y Tong, H Zhan, ... Nature biotechnology 24 (1), 73-75, 2006 | 308 | 2006 |
| Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness E Wang, LD Miller, GA Ohnmacht, S Mocellin, A Perez-Diez, D Petersen, ... Cancer research 62 (13), 3581-3586, 2002 | 298 | 2002 |
| Identification of cell cycle-regulated genes in fission yeast X Peng, RKM Karuturi, LD Miller, K Lin, Y Jia, P Kondu, L Wang, LS Wong, ... Molecular biology of the cell 16 (3), 1026-1042, 2005 | 214 | 2005 |
| Optimal gene expression analysis by microarrays LD Miller, PM Long, L Wong, S Mukherjee, LM McShane, ET Liu Cancer cell 2 (5), 353-361, 2002 | 205 | 2002 |
| Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling SW Nam, JY Park, A Ramasamy, S Shevade, A Islam, PM Long, CK Park, ... Hepatology 42 (4), 809-818, 2005 | 194 | 2005 |
| Sal‐like protein 4 (SALL4), a stem cell biomarker in liver cancers T Oikawa, A Kamiya, M Zeniya, H Chikada, AD Hyuck, Y Yamazaki, ... Hepatology 57 (4), 1469-1483, 2013 | 190 | 2013 |
| Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome J Frasor, EC Chang, B Komm, CY Lin, VB Vega, ET Liu, LD Miller, ... Cancer research 66 (14), 7334-7340, 2006 | 186 | 2006 |
| An iron regulatory gene signature predicts outcome in breast cancer LD Miller, LG Coffman, JW Chou, MA Black, J Bergh, R D'Agostino, ... Cancer research 71 (21), 6728-6737, 2011 | 179 | 2011 |
| CDKN1C (p57 KIP2) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells X Yang, RKM Karuturi, F Sun, M Aau, K Yu, R Shao, LD Miller, PBO Tan, ... PloS one 4 (4), e5011, 2009 | 175 | 2009 |
